Clinical Fellow, Cancer Immunotherapy
The Fred Hutchinson Cancer Research Center seeks qualified candidates for clinical and/or translational research fellowships in Cancer Immunotherapy. Successful candidates will be physicians who will work with faculty members in the Immunotherapy Integrated Research Center (IIRC, IIRC Membership) and have the opportunity to develop an academic career through mentored training in clinical and/or translational research to develop immunotherapies for cancer.
The Immunotherapy IRC will make a commitment to the fellow for clinical and/or translational research training.
- During the first 3-6 months, the fellow will participate in patient care on inpatient and outpatient cancer immunotherapy services. They will work closely with both clinical and research teams, and will develop the skills necessary to manage patients enrolled in the wide range of immunotherapy trials being conducted across the Fred Hutch/University of Washington Cancer Consortium. In this clinical training period, the fellows will conduct only incidental patient care and will be expected to immerse themselves in the clinical and/or translational research environment at Fred Hutch, with a goal of identifying a physician/scientist mentor within the IIRC (IIRC Membership), who will train and support them in a novel immunotherapy research project to be conducted for the remainder of the 2 year appointment. Candidates may identify projects that require guidance from more than one mentor, as long as one mentor is a physician/scientist member of the IIRC.
- After initial clinical training and identification of a mentor and research project, the fellow will develop their research project under the guidance of the mentor. Projects may be predominantly clinical, correlative, or laboratory-based, and must be focused on the development and improvement of clinical or translational cancer immunotherapy.
Funding for the fellow’s salary will be available for 2 years; however, fellows are strongly encouraged to apply for outside funding during their first year with support from their mentor.
Fred Hutch is a world leader in immunotherapy (more information at FH immunotherapy), with resources including outstanding staff, facilities and infrastructure necessary to support translational immunotherapy research. Resources include:
- An exceptionally strong history of research in immunotherapy (FH immunotherapy) and bone marrow transplantation (FH transplantation) that informs and guides progress towards the development of the next generation of curative therapies.
- The first cancer clinic dedicated exclusively to cellular immunotherapy clinical trials (Bezos Family Immunotherapy Clinic), located at the Seattle Cancer Care Alliance, an outpatient cancer clinic on the Fred Hutch campus.
- Extensive expertise and facilities for the manufacture of clinical grade products, including cellular, biologic, and DNA-based therapeutics (Therapeutic Products). These facilities support more than 25 investigator initiated, Phase I clinical trials each year.
- A large network of cutting edge shared resource laboratories (Shared Resources) staffed by experts, who can assist in experimental design, assay development, and statistical analyses.
- MD, MD/PhD or foreign equivalent
- Completion of fellowship in Hematology/Oncology or foreign equivalent
- Demonstrated interest and accomplishments in clinical or laboratory cancer immunotherapy or immunology research.